• 1
    Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies. I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 1984; 16: 193208.
  • 2
    Oddis CV. Idiopathic inflammatory myopathy. In: WortmannRL, editor. Diseases of skeletal muscle. Philadelphia: Lippincott Williams & Wilkins; 2000. p. 4586.
  • 3
    Sultan SM. Clinical assessment in adult onset idiopathic inflammatory myopathy. Curr Opin Rheumatol 2004; 16: 66872.
  • 4
    Nishikai M, Reichlin M. Heterogeneity of the precipitating antibodies in polymyositis and dermatomyositis: characterization of the Jo-1 antibody system. Arthritis Rheum 1980; 23: 8818.
  • 5
    Marguerie C, Bunn CC, Beynon HL, Bernstein RM, Hughes JM, So AK, et al. Polymyositis, pulmonary fibrosis, and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 1990; 77: 101938.
  • 6
    Arsura E, Greenberg A. Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis. Semin Arthritis Rheum 1988; 18: 2937.
  • 7
    Marie I, Hachulla E, Cherin P, Dominique S, Hatron PY, Hellot M, et al. Interstitial lung disease in polymyositis and dermatomyositis. Arthritis Rheum 2002; 47: 61422.
  • 8
    Douglas W, Tazelaar H, Hartman R, Hartman T, Decker P, Schroeder D, et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001; 164: 11825.
  • 9
    Targoff IN. Humoral immunity in polymyositis/dermatomyositis. J Invest Dermatol 1993; 100: 11623S.
  • 10
    Raben N, Nichols R, Dohlman J, McPhie P, Sridhar V, Hyde C, et al. A motif in human histidyl-tRNA synthetase which is shared among several aminoacyl-tRNA synthetases is a coiled-coil that is essential for enzymatic activity and contains the major autoantigenic epitope. J Biol Chem 1994; 269: 2427783.
  • 11
    Martin A, Shulman MJ, Tsui FW. Epitope studies indicate that histidyl-tRNA synthetase is a stimulating antigen in idiopathic myositis. FASEB J 1995; 9: 122633.
  • 12
    Miller FW, Twitty SA, Biswas T, Plotz PH. Origin and regulation of a disease-specific autoantibody response: antigenic epitopes, spectrotype stability, and isotype restriction of anti-Jo-1 antibodies. J Clin Invest 1990; 85: 46875.
  • 13
    Miller FW, Waite KA, Biswas T, Plotz PH. The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity. Proc Natl Acad Sci U S A 1990; 87: 99337.
  • 14
    Yoshida S, Akizuki M, Mimori T, Yamagata H, Inada S, Homma M. The precipitating antibody to an acidic nuclear protein antigen, the Jo-1, in connective tissue diseases: a marker for a subset of polymyositis with interstitial pulmonary fibrosis. Arthritis Rheum 1983; 26: 60411.
  • 15
    Bernstein RM, Morgan SH, Chapman J, Bunn CC, Mathews MB, Turner-Warwick M, et al. Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br Med J (Clin Res Ed) 1984; 289: 1512.
  • 16
    Isenberg D, Allen E, Farewell V, Ehrenstein M, Hanna M, Lundberg I, et al. International consensus outcome measures for patients with idiopathic inflammatory myopathies: development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) 2004; 43: 4954.
  • 17
    Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 3447.
  • 18
    Ravirajan CT, Rowse L, MacGowan JR, Isenberg DA. An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study. Rheumatology (Oxford) 2001; 40: 140512.
  • 19
    Engel AG, Arahata K. Mononuclear cells in myopathies: quantitation of functionally distinct subsets, recognition of antigen-specific cell-mediated cytotoxicity in some diseases, and implications for the pathogenesis of the different inflammatory myopathies. Hum Pathol 1986; 17: 70421.
  • 20
    Tateyama M, Nagano I, Yoshioka M, Chida K, Nakamura S, Itoyama Y. Expression of tumor necrosis factor-α in muscles of polymyositis. J Neurol Sci 1997; 146: 4551.
  • 21
    Sugiura T, Murakawa Y, Nagai A, Kondo M, Kobayashi S. Fas and Fas ligand interaction induces apoptosis in inflammatory myopathies: CD4+ T cells cause muscle injury directly in polymyositis. Arthritis Rheum 1999; 42: 2918.
  • 22
    Ascherman DP, Oriss T, Oddis CV, Wright TM. Critical requirement for professional APCs in eliciting T cell responses to novel fragments of histidyl-tRNA synthetase (Jo-1) in Jo-1 antibody-positive polymyositis. J Immunol 2002; 169: 712734.